Di Yi Cai Jing·2025-08-16 01:46Core Insights - The trend of local procurement for scientific reagents in China is increasing, particularly after the pandemic and amid uncertainties in US-China tariff negotiations [2][3] - Domestic companies are gaining market share in the scientific reagent sector, with firms like Titan Technology and Novogene seeing significant stock price increases [2] - The Chinese government is actively promoting the innovation and development of domestic scientific instruments and reagents, aiming for substantial growth in the industry by 2027 [3] Industry Dynamics - Major multinational suppliers of scientific reagents include Thermo Fisher, Merck, Danaher, and Agilent, which have historically dominated the market [2] - Domestic manufacturers are noted for their cost advantages and delivery flexibility, which are becoming increasingly attractive to local drug research and development companies [2][3] - Despite the rise of local firms, multinational companies still maintain a strong technological edge, particularly in high-end products [4][5] Market Trends - The Chinese reagent market is projected to grow by over 10% annually, driven by government support and increasing drug research activities [3] - Multinational companies are responding to market changes by investing in local manufacturing capabilities, such as Merck's €70 million investment in a new reagent production facility in Nantong [5][6] - Collaborations between multinational instrument manufacturers and local reagent companies are emerging, indicating a shift towards integrated solutions in the market [6]